Skip to main content
Retour
Watch Compare

Retrieve Medical Holdings, Inc.

Qualité des données : 83%
RMHI
OTC Manufacturing Chemicals
1,03 €
0,00 € (0,00%)
6 months return
—
Momentum
Neutral
Free cash flow
-55 834,0

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROIC-148,04%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current RatioN/A
Interest Coverage-8,84

Valorisation

PE (TTM)
-117,85
En dessous de la moyenne du secteur (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -55 834,0

Price History

Tendances Financières

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: N/A · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -217 856,0
ROE N/A ROA -184,18%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -55 834,0
ROIC -148,04% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: N/A
Debt / Equity N/A Current Ratio N/A
Interest Coverage -8,84 Asset Turnover N/A
Working Capital N/A Tangible Book Value -603 396

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -117,85 · EV/EBITDA: N/A
P/E Ratio -117,85 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -0,22%
Market Cap 25,67 M Enterprise Value 25,67 M

Per Share

EPS: N/A · FCF/Share: 0,00
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 25,63% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 25,63%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2022 FY2021 FY2020 FY2019 FY2018
Revenue — — — — —
Net Income -164 969,0 -76 089,0 -15 011,0 -13 993,0 -28 407,0
EPS (Diluted) — — — — —
Gross Profit — — — — —
Operating Income -163 302,0 -68 721,0 -5 535,0 -5 684,0 -27 823,0
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 32 081,0 10 397,0 9 476,0 8 309,0 5 584,0
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2022 FY2021 FY2020 FY2019 FY2018
Total Assets 130 349,0 261 152,0 408,0 527,0 2 270,0
Total Liabilities 621 503,0 587 337,0 250 504,0 235 612,0 223 362,0
Shareholders' Equity -491 154,0 -326 185,0 -250 096,0 -235 085,0 -221 092,0
Total Debt — — — — —
Cash & Equivalents — — 0,0 0,0 0,0
Current Assets — — 408,0 527,0 2 270,0
Current Liabilities — — 250 504,0 235 612,0 223 362,0

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1605 pairs)
Métrique Action Médiane du Secteur
P/E -117,9 -1,5
P/B — 1,6
ROE % — -54,7
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3